Overview

Different Dose of Methotrexate for the Treatment of Meningeal Carcinomatosis

Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to compare the effect of 10 mg and 15 mg methotrexate in the treatment of meningeal carcinomatosis.
Phase:
Phase 4
Details
Lead Sponsor:
Hui Bu
Treatments:
Methotrexate